Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Other Income (Expense) : ¥-49 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shandong Jincheng Pharmaceutical Group Co Other Income (Expense)?

Shandong Jincheng Pharmaceutical Group Co's other income expense for the Shandong Jincheng Pharmaceutical Group Co's pretax income for the three months ended in Mar. 2024 was ¥2 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-49 Mil.

Shandong Jincheng Pharmaceutical Group Co Other Income (Expense) Historical Data

The historical data trend for Shandong Jincheng Pharmaceutical Group Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Jincheng Pharmaceutical Group Co Other Income (Expense) Chart

Shandong Jincheng Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Expense)

Get a 7-Day Free Trial

-151.28

-794.09

-68.51

-44.46

-52.10

Shandong Jincheng Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Expense)	Get a 7-Day Free Trial															-0.69	-8.08	-13.52	-29.81	2.32

Shandong Jincheng Pharmaceutical Group Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-49 Mil.

Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Shandong Jincheng Pharmaceutical Group Co Ltd (SZSE:300233) » Definitions » Other Income (Expense)

Traded in Other Exchanges

N/A

Address

No. 1 Shuangshan Road, Zichuan Economic Development Zone, Shandong, Zibo, CHN, 255100

Website

http://www.jinchengpharm.com

Shandong Jincheng Pharmaceutical Group Co Ltd is engaged in the research and development, production and sale of III and IV cephalosporin intermediates and biopharmaceuticals. It offers characteristic bulk drugs, pharmaceutical intermediates, and fine chemicals. The company distributes its products within domestic market and to overseas markets.

Executives

Yang Xiu Liang	Executives
Zhang Xue Bo	Director
Zheng Geng Xiu	Director
Zhao Ye Qing	Director
Sun Rui Mei	Executives
Cui Xi Li	Executives
Zhao Hong Fu	Director
Fu Miao Qing	Executives
Zhu Xiao Gang	Directors, executives
Li Jia Quan	Directors, executives
Guo Fang Shui	Supervisors
Chou Qiang	Securities Affairs Representative

Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Headlines

No Headlines